TRACY GEORGE, MD - EXECUTIVE DIRECTOR OF CLINICAL TRIALS AND PHARMADX AT ARUP LABORATORIES - Preview 1
Update: 2020-06-05
Description
September 25, 1998 - trastuzumab, one of the first targeted therapies with a companion diagnostic, received #FDA approval in breast #cancer.
The commercially available IHC and FISH companion #diagnostics were not incorporated into the pivotal clinical trial. They had to be subsequently "developed" and validated by way of concordance studies (which were not stellar).
Does this still happen today? Have we begun to appreciate the importance of embedding companion diagnostics directly into clinical trials?
The commercially available IHC and FISH companion #diagnostics were not incorporated into the pivotal clinical trial. They had to be subsequently "developed" and validated by way of concordance studies (which were not stellar).
Does this still happen today? Have we begun to appreciate the importance of embedding companion diagnostics directly into clinical trials?
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
